Key Points - Robbins LLP files a class action lawsuit against Flotek Industries, Inc. - Bronstein, Gewirtz & Grossman LLC also urge investors to take action against Flotek. - Levi & Korsinsky alerts investors to the lead plaintiff deadline for the securities class action. - Flotek Industries experiences a significant decline in share value after...
Key Points - Multiple law firms, including Kahn Swick & Foti, LLP and Kaplan Fox &...
Key Points - Kaplan Fox & Kilsheimer LLP announces a class action lawsuit against Hyliion Holdings...
Following are the Top 5 companies based on their one-day percentage change within the 'Smart Transportation...
Following are the Top 5 companies based on their one-day percentage change within the 'Fintech ETFs'...
Ryan Meyers from Lake Street issued a price target of $6.00 for LFVN on 2026-08-28 12:51:29.The adjusted price target was set to $6.00.At the time of the announcement, LFVN was...
from Ascendiant issued a price target of $5.00 for GNSS on 2026-08-28 10:53:37.The adjusted price target was set to $5.00.At the time of the announcement, GNSS was trading at $1.55.The...
from CLSA issued a price target of $3.80 for BZUN on 2026-08-28 08:45:48.The adjusted price target was set to $3.80.At the time of the announcement, BZUN was trading at $3.02.The...
Jake Fuller from BTIG issued a price target of $35.00 for REAX on 2026-08-27 14:34:27.The adjusted price target was set to $35.00.At the time of the announcement, REAX was trading...
from Lake Street issued a price target of $25.00 for OOMA on 2026-08-27 12:44:54.The adjusted price target was set to $25.00.At the time of the announcement, OOMA was trading at...
In a landscape marked by rapid technological advancements, the company saw a revenue increase of $1.4 million for the three months ending September 30, 2024, fueled by new licenses and...
In a landscape of fluctuating revenues, the company celebrated a 25% revenue increase in Q3 2024, yet faced a 14% decline over nine months due to production challenges. Operating expenses...
In a landscape marked by financial challenges, the company faced fluctuating revenues, with a notable 25% increase in Q3 2024 overshadowed by a 14% decline over nine months. Operating losses...
In a tale of growth and ambition, the company witnessed its revenue soar from $6.0 million to $13.9 million, fueled by partnerships with Acadia Pharmaceuticals. However, operating expenses, particularly in...
In a transformative period, the company experienced a remarkable surge in revenue, driven by newly acquired oil and gas assets. Operating expenses showed notable trends, with a decrease in occupancy...
